Ikena Oncology, Inc.IKNANASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank86
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P86
Within normal range
Average
-758.68%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%+100.0%
2023-812.19%-80.8%
2022-449.18%-314.3%
2021-108.42%+77.5%
2020-480.95%-260.1%
2019-133.57%+96.7%
2018-4085.15%-